ReShape Lifesciences Inc. (RSLS)

Market Cap	4.05M
Revenue (ttm)	8.68M
Net Income (ttm)	-11.39M
Shares Out	23.46M
EPS (ttm)	-1.91
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	296,604
Open	0.174
Previous Close	0.178
Day's Range	0.167 - 0.183
52-Week Range	0.141 - 2.798
Beta	1.30
Analysts	n/a
Price Target	n/a
Earnings Date	May 13, 2024

About RSLS

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCar...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 15, 2007
• Employees: 29
• Stock Exchange: NASDAQ
• Ticker Symbol: RSLS

Financial Performance

In 2023, RSLS's revenue was $8.68 million, a decrease of -22.79% compared to the previous year's $11.24 million. Losses were -$11.39 million, -75.36% less than in 2022.